Angelova-Fischer et al. [60] reported that non-lesional skin of AD filaggrin mutation carriers had a decreased ceramide/cholesterol ratio in comparison to the non-filaggrin AD type and healthy controls. Here, FLG is linked to Alzheimer disease.